2nd Arthritis Alliance Conference and Research Symposium

First Page		Document Content
Date: 2014-10-14 13:39:59 Ravinder N. Maini Marc Feldmann TNF inhibitor Rheumatology Arthritis Rheumatoid arthritis Biologic Peter K. Gregersen Medicine Rheumatologists Health		2nd Arthritis Alliance Conference and Research Symposium Add to Reading List Source URL: www.gairdner.org Download Document from Source Website File Size: 183,61 KB Share Document on Facebook

	ADVANCES IN RHEUMATOLOGY Affiliated with Columbia University College of Physicians and Surgeons and Weill Cornell Medical College NOVEMBER/DECEMBER 2014 The rheumatology program at NewYorkPresbyterian Hospital is compris DocID: 1fzzx - View Document
	Presentation of Navigare Patient Flow and Positioning Product Group: Biological Drugs Target Groups: Rheumatologists Dermatologists Gastroenterologists Countries: DocID: 1eAsN - View Document
	Developed in Partnership with Rheumatologists Raintree Delivers EMR and Practice Management in a Single Software Solution DocID: 1d2Up - View Document
	Important Safety Information for Rheumatologists About Risks in Patients Receiving ACTEMRA® ACTEMRA® (tocilizumab) is an interleukin-6 (IL-6) receptor antagonist that has been approved by the Food and Drug Administrati DocID: 1bTad - View Document
	542 CONCISE REPORT Formative research in clinical trial development: attitudes of patients with arthritis in enhancing prevention trials DocID: 1anTs - View Document